$9.10 +0.05 (%) Achillion Pharmaceuticals Inc - NASDAQ

May. 26, 2016 | 03:04 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Achillion Names Dr. Joel Barrish as Chief Scientific Officer

    Benzinga | Jan. 4, 2016 | 06:21AM EST
  2. Najarian Brothers Are Bullish On American Airlines And Achillion Pharma

    Benzinga | Dec. 31, 2015 | 08:20AM EST
  3. Achillion Announces Upcoming Oral Presentation and Nomination of ACH-4471 at #ASH2015

    Benzinga | Dec. 6, 2015 | 08:38AM EST
  4. Achillion Announces Janssen Initiated Phase 2a Study to Evaluate Combination of AL-335, ACH-3102, and Simeprevir for Treatment of Genotype 1 Chronic HCV

    Benzinga | Oct. 16, 2015 | 06:07AM EST
  5. UBS: Biotech Will Continue To Outperform In 2015

    Benzinga | Sep. 8, 2015 | 13:22PM EST
  6. Morning Market Gainers

    Benzinga | Sep. 8, 2015 | 09:45AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 8, 2015 | 08:15AM EST
  8. Achillion to Present at Baird, Morgan Stanley Conferences

    Benzinga | Sep. 1, 2015 | 06:57AM EST
  9. Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics

    Benzinga | Aug. 3, 2015 | 04:20AM EST
  10. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  11. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  12. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 13:56PM EST
  13. Morning Market Losers

    Benzinga | Jun. 22, 2015 | 09:49AM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 22, 2015 | 08:19AM EST
  15. UBS and JMP Securities Downgrade Achillion Pharmaceuticals Inc. ...

    GuruFocus | May. 21, 2015 | 18:41PM EST
  16. What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?

    Benzinga | May. 21, 2015 | 08:27AM EST
  17. Achillion

    IBD | May. 20, 2015 | 18:39PM EST
  18. Dycom Industries (DY) Surpasses Estimates; Achillion Pharma (ACHN) Inks Mega-Deal with Janssen

    GuruFocus | May. 20, 2015 | 17:12PM EST
  19. Achillion Dives As J&J Hep C Deal Chills Buyout Buzz

    IBD | May. 20, 2015 | 13:52PM EST
  20. Morning Market Losers

    Benzinga | May. 20, 2015 | 09:56AM EST
  21. Benzinga's Top Downgrades

    Benzinga | May. 20, 2015 | 09:46AM EST
  22. JMP Securities Downgrades Achillion Pharmaceuticals To Market Perform

    Benzinga | May. 20, 2015 | 09:04AM EST
  23. JMP Says Stepping To The Sidelines On Achillion

    Benzinga | May. 20, 2015 | 08:54AM EST
  24. ACHILLION PHARMA

    IBD | May. 19, 2015 | 18:30PM EST
  25. Achillion, J&J To Jointly Develop Hepatitis C Drugs

    IBD | May. 19, 2015 | 17:07PM EST
  26. Morning Market Losers

    Benzinga | May. 19, 2015 | 09:49AM EST
  27. Benzinga's Top #PreMarket Losers

    Benzinga | May. 19, 2015 | 08:15AM EST
  28. Momo, Take-Two, Urban Outfitters Lead Monday's After-Hours Movers

    Benzinga | May. 18, 2015 | 18:47PM EST
  29. After-Hours Movers Led By Bob Evans, Bazaarvoice And Smith & Wesson On Tuesday

    Benzinga | Mar. 3, 2015 | 17:58PM EST
  30. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga | Feb. 17, 2015 | 12:17PM EST
  31. US Stock Futures Up Ahead Of Jobless Claims, Retail Sales Data

    Benzinga | Feb. 12, 2015 | 07:30AM EST
  32. Morning Market Losers

    Benzinga | Feb. 11, 2015 | 10:00AM EST
  33. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 11, 2015 | 08:25AM EST
  34. JMP Securities Covers Mostly Good News From Pharma Pending More Visibility

    Benzinga | Feb. 11, 2015 | 07:54AM EST
  35. Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial

    GuruFocus | Feb. 10, 2015 | 12:36PM EST
  36. Morning Market Gainers

    Benzinga | Feb. 9, 2015 | 09:48AM EST
  37. Achillion Pharmaceuticals Shares Surge On Positive Data

    Benzinga | Feb. 9, 2015 | 09:34AM EST
  38. Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

    Benzinga | Feb. 9, 2015 | 09:05AM EST
  39. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 9, 2015 | 08:07AM EST
  40. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  41. Worst Performing Industries For February 4, 2015

    Benzinga | Feb. 4, 2015 | 11:05AM EST
  42. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  43. Deutsche Bank's Top Biotech Picks For 2015

    Benzinga | Jan. 22, 2015 | 11:09AM EST
  44. Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014

    GuruFocus | Jan. 9, 2015 | 10:25AM EST
  45. The Top 5 Biotech Gainers Of 2014

    Benzinga | Dec. 29, 2014 | 14:15PM EST
  46. Morning Market Movers

    Benzinga | Dec. 29, 2014 | 09:51AM EST
  47. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 29, 2014 | 08:04AM EST
  48. Morning Market Movers

    Benzinga | Dec. 24, 2014 | 09:42AM EST
  49. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 24, 2014 | 08:09AM EST
  50. Mid-Day Losers From December 23: Achillion Pharmaceuticals, Doral Financial, Keurig Green Mountain And More

    Benzinga | Dec. 23, 2014 | 13:44PM EST
Trading Center